ABCG2 and liver cancer: In terms of HCC, a recent study has proven that high SOX9 expression levels indicate tumor aggressiveness in liver cancer and enhance sorafenib resistance by modulating ATP binding cassette sub-family G member 2(ABCG2) expression [11].